Clinical analysis has indicated that evidence of M2 polarization of ovarian tumor-associated macrophages, including high CD163 expression and high ascites IL-6 and IL-10 levels, correlates with poor clinical outcomes [10], although in many patients gene expression profiles revealed a mixed phenotype that was not amenable to M1/M2 assignment. The gene discussed is IL10; the disease is ovarian neoplasm.